The extracellular regulation of bone morphogenetic protein signaling
Development2009Vol. 136(22), pp. 3715–3728
Citations Over TimeTop 10% of 2009 papers
Abstract
In many cases, the level, positioning and timing of signaling through the bone morphogenetic protein (BMP) pathway are regulated by molecules that bind BMP ligands in the extracellular space. Whereas many BMP-binding proteins inhibit signaling by sequestering BMPs from their receptors, other BMP-binding proteins cause remarkably context-specific gains or losses in signaling. Here, we review recent findings and hypotheses on the complex mechanisms that lead to these effects, with data from developing systems, biochemical analyses and mathematical modeling.
Related Papers
- → Distribution of bone morphogenetic protein and bone morphogenetic protein receptor transcripts in the rodent nervous system and up-regulation of bone morphogenetic protein receptor type II in hippocampal dentate gyrus in a rat model of global cerebral ischemia(2000)102 cited
- → Bone morphogenetic protein-2, but not bone morphogenetic protein-7, promotes dendritic growth and calbindin phenotype in cultured rat striatal neurons(2001)23 cited
- → Osteoinductive ability of confluent Saos‐2 cells correlates with enhanced expression of bone morphogenetic proteins(1996)11 cited
- Regeneration of bone and beyond(2004)
- From local to systemic therapeutics(2008)